Differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factors
Differentiation syndrome is a treatment complication which can occur in acute promyelocytic leukemia (APL) patients treated with all-trans retinoic acid (ATRA) or arsenic trioxide (ATO), which is characterized by enhanced leukocyte transmigration. Several cellular and molecular mechanisms participate in differentiation syndrome development. This review discusses the changes in expression of adhesion molecules induced during ATRA and ATO treatments and their possible implications in the pathogenesis of this potentially fatal complication.
Main Authors: | , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular
2008
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842008000800009 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1516-84842008000800009 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1516-848420080008000092008-12-09Differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factorsRego,Eduardo M.Santana-Lemos,Bárbara A. A.Tamarozzi,Mirela B. Acute promyelocytic leukemia adhesion molecules retinoids arsenic trioxide Differentiation syndrome is a treatment complication which can occur in acute promyelocytic leukemia (APL) patients treated with all-trans retinoic acid (ATRA) or arsenic trioxide (ATO), which is characterized by enhanced leukocyte transmigration. Several cellular and molecular mechanisms participate in differentiation syndrome development. This review discusses the changes in expression of adhesion molecules induced during ATRA and ATO treatments and their possible implications in the pathogenesis of this potentially fatal complication.info:eu-repo/semantics/openAccessAssociação Brasileira de Hematologia e Hemoterapia e Terapia CelularRevista Brasileira de Hematologia e Hemoterapia v.30 suppl.2 20082008-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842008000800009en10.1590/S1516-84842008000800009 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Rego,Eduardo M. Santana-Lemos,Bárbara A. A. Tamarozzi,Mirela B. |
spellingShingle |
Rego,Eduardo M. Santana-Lemos,Bárbara A. A. Tamarozzi,Mirela B. Differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factors |
author_facet |
Rego,Eduardo M. Santana-Lemos,Bárbara A. A. Tamarozzi,Mirela B. |
author_sort |
Rego,Eduardo M. |
title |
Differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factors |
title_short |
Differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factors |
title_full |
Differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factors |
title_fullStr |
Differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factors |
title_full_unstemmed |
Differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factors |
title_sort |
differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factors |
description |
Differentiation syndrome is a treatment complication which can occur in acute promyelocytic leukemia (APL) patients treated with all-trans retinoic acid (ATRA) or arsenic trioxide (ATO), which is characterized by enhanced leukocyte transmigration. Several cellular and molecular mechanisms participate in differentiation syndrome development. This review discusses the changes in expression of adhesion molecules induced during ATRA and ATO treatments and their possible implications in the pathogenesis of this potentially fatal complication. |
publisher |
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular |
publishDate |
2008 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842008000800009 |
work_keys_str_mv |
AT regoeduardom differentiationsyndromeinacutepromyelocyticleukemiapathogenesisandriskfactors AT santanalemosbarbaraaa differentiationsyndromeinacutepromyelocyticleukemiapathogenesisandriskfactors AT tamarozzimirelab differentiationsyndromeinacutepromyelocyticleukemiapathogenesisandriskfactors |
_version_ |
1756423451095072768 |